Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1979 Dec;40(6):883–889. doi: 10.1038/bjc.1979.281

The quantitative response of human tumours to radiation and misonidazole.

D V Ash, M J Peckham, G G Steel
PMCID: PMC2010139  PMID: 526430

Abstract

Eleven patients with measurable subcutaneous or pulmonary metastases were selected for a study of the effectiveness of the radiosensitizer misonidazole (MIS). Evaluable data were obtained in 6 patients and radiosensitization demonstrated in 5. Patients were irradiated either before or after MIS, and each patient acted as his own control. Response to treatment in 5 cases was assessed in terms of growth delay, and radiation doses were selected in expectation of enhancement ratios of 1.2 to 1.5. In 1 case evidence of sensitization was obtained from differential tumour clearance from 2 areas of skin irradiated before or after MIS. Results in 4/5 growth-delay studies indicated enhancement ratios ranging from 1.1 to greater than 1.5. An enhancement ratio of 1.3 was measured in a case of squamous carcinoma treated by a 10-fraction course of irradiation. Evidence of sensitization was obtained in breast carcinoma, osteosarcoma, leiomyosarcoma, prostatic carcinoma and synoviosarcoma. The results of this study support the view that MIS may improve the radiotherapeutic management of a wide range of tumours, although more extensive data are required to identify those categories of disease in which greatest benefit will be obtained, and to indicate the optimum radiation schedule.

Full text

PDF
883

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown J. M., Yu N. Y., Cory M. J., Bicknell R. B., Taylor D. L. In vivo evaluation of the radiosensitizing and cytotoxic properties of newly synthesized electron-affinic drugs. Br J Cancer Suppl. 1978 Jun;3:206–211. [PMC free article] [PubMed] [Google Scholar]
  2. Dawen P. J., Peckham M. J., Steel G. G. The response of human tumour metastases to radiation and misonidazole. Br J Cancer Suppl. 1978 Jun;3:290–296. [PMC free article] [PubMed] [Google Scholar]
  3. Denekamp J., Fowler J. F., Dische S. The proportion of hypoxic cells in a human tumor. Int J Radiat Oncol Biol Phys. 1977 Nov-Dec;2(11-12):1227–1228. doi: 10.1016/0360-3016(77)90140-7. [DOI] [PubMed] [Google Scholar]
  4. Denekamp J., Fowler J. F. Radiosensitization of solid tumors by nitroimidazoles. Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):143–151. doi: 10.1016/0360-3016(78)90130-x. [DOI] [PubMed] [Google Scholar]
  5. Denekamp J., McNally N. J. The magnitude of hypoxic cell cytotoxicity of misonidazole in human tumours. Br J Radiol. 1978 Sep;51(609):747–748. doi: 10.1259/0007-1285-51-609-747. [DOI] [PubMed] [Google Scholar]
  6. Dische S., Gray A. J., Zanelli G. D. Clinical testing of the radiosensitiser Ro-07-0582. II. Radiosensitisation of normal and hypoxic skin. Clin Radiol. 1976 Apr;27(2):159–166. doi: 10.1016/s0009-9260(76)80138-9. [DOI] [PubMed] [Google Scholar]
  7. Dische S., Zanelli G. D. Skin reaction. A quantitative system for measurement of radiosensitisation in man. Clin Radiol. 1976 Apr;27(2):145–149. doi: 10.1016/s0009-9260(76)80135-3. [DOI] [PubMed] [Google Scholar]
  8. Hill R. P., Bush R. S. The effect of misonidazole in combination with radiation dose fractionation. Br J Cancer Suppl. 1978 Jun;3:255–258. [PMC free article] [PubMed] [Google Scholar]
  9. Pedersen J. E., Smith M. R., Bugden R. D., Peckham M. J. Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice. Br J Cancer. 1979 Apr;39(4):429–433. doi: 10.1038/bjc.1979.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sheldon P. W., Fowler J. F. Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour. Br J Cancer Suppl. 1978 Jun;3:242–245. [PMC free article] [PubMed] [Google Scholar]
  11. Stratford I. J., Adams G. E. The toxicity of the radiosensitizer misonidazole towards hypoxic cells in vitro: a model for mouse and man. Br J Radiol. 1978 Sep;51(609):745–746. doi: 10.1259/0007-1285-51-609-745. [DOI] [PubMed] [Google Scholar]
  12. Thomlinson R. H., Dische S., Gray A. J., Errington L. M. Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours. Clin Radiol. 1976 Apr;27(2):167–174. doi: 10.1016/s0009-9260(76)80139-0. [DOI] [PubMed] [Google Scholar]
  13. Watson E. R., Halnan K. E., Dische S., Saunders M. I., Cade I. S., McEwen J. B., Wiernik G., Perrins D. J., Sutherland I. Hyperbaric oxygen and radiotherapy: a Medical Research Council trial in carcinoma of the cervix. Br J Radiol. 1978 Nov;51(611):879–887. doi: 10.1259/0007-1285-51-611-879. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES